https://www.zonebourse.com/cours/action/THERATECHNOLOGIES-INC-1411917/actualite/Theratechnologies-Inc-passe-a-la-dose-superieure-dans-son-etude-clinique-de-phase-1-sur-le-sudoc-46259851/?utm_source=telegram&utm_medium=social&utm_campaign=share